Australian Wholesale Investors continue to allocate a greater proportion of their investment funds toward alternative assets such as private equity where there is the possibility of outperforming public markets and achieving uncorrelated investment returns. Our Evergreen Fund is dedicated to investing in only those funds and investments established and managed by Crescent.
While the Fund is open, Wholesale Investors will have access to Crescent’s forthcoming core private equity fund, “Crescent Capital Partners VIII”, as well as access to the smaller-cap “Crescent Growth I” and any continuation funds or co-investments in which Crescent’s private equity funds are investing.
There is a “no capital call” structure, with investors’ subscription monies being invested immediately into Crescent’s corporate loan strategies pending deployment into the private equity program. This unique process will help minimise the investment return drag that would typically be associated with a “no capital call” structure.
Wholesale investors can access the Evergreen Fund either directly through completing the form below, or through financial advisers who have access to the following investment platforms.
Over 35 years in strategy consulting, investment and business management and public company boards.
Ex Bain & Company, LEK Partnership and Chase Manhattan Bank.
Chair: Australian Clinical Labs (ASX), Steel Mains, Green Leaves, Bremick, Seagrass, NZ Panels Group.
Michael Alscher
Founder, Managing Partner – BComm
35+ years experience in financial management and accounting.
Ex Saffery (London)
Peter Lyon-Mercado
Partner – BEng (Civil) (Hons), FCA, SA Fin
35+ years in the healthcare sector, both as a CEO and in private equity investing.
Ex Co-founder and CEO of Life Healthcare Group Limited (ASX:LHC), COO of MIA Group Limited, CEO Healthcare of Australia (Mayne Group)
Chair: Healthcare Australia, Pinnacle Rehab and Australia Institute of Business
Daren McKennay
Partner – BBus, MBA, CA
40+ years experience in operating roles and M&A.
Ex Global Deputy Chairman of Tyco Fire & Security and former CEO of Tyco Fire and Security Asia Pacific.
Chair: NZ Panels Group, Viridian, Oceania, Hall Contracting, Director of Cardno Ltd (ASX), Seagrass, and Steel Mains.
Neville Buch
Partner – BSc Eng (Hons), MBA
25 years experience in strategy consulting, private equity and banking.
Ex McKinsey & Company.
Chair: National Dental Care, Airesafe, Cardno Ltd (ASX). Director of Australian Clinical Labs, ClearView Ltd (ASX), Emapta.
Nathanial Thomson
Partner – BComm (Hons), LlB (Hons)
15+ years experience in strategy consulting and private equity
Ex A.T. Kearney
Chair: EMAPTA, Walski.
Stuart Butterworth
Partner – BA / LLB (First Class)
16+ years experience in private equity and investment banking focussed on consumer and healthcare in ANZ, Europe and Asia. Extensive NED experience globally.
Ex Managing Director & Head of ANZ at L Catterton, Investment Director at New Hope Group, Executive Director Goldman Sachs Consumer Healthcare, Nomura and UBS.
Ondrej Ruzicka
Managing Partner Crescent Growth – B.Bus, MBA
10+ years experience in private equity, strategy consulting and M&A
Ex McKinsey & Company, King & Wood Mallesons
Director: Pinnacle Rehab
Patrick Schmidt
Investment Director – BComm (Fin)/LLB (First Class Hons), MBA
Extensive experience in private equity and investment banking with focus on consumer and healthcare sectors.
Ex Principal at L Catterton, Investment Banking Associate Goldman Sachs Consumer Healthcare, Pacific Capital and Citi.
Giuseppe Valletta
Investment Director – BSc(physics), MSc(physics)
12+ years experience in private equity
Ex Ernst and Young
Eugen Lamotte
CFO Private Equity Funds – BComm, Master Financial Analysis
If you are interested in knowing more about Crescent Capital’s Private Equity Evergreen Fund and would like to receive the Information Memorandum and access to invest, please complete the form below.